For surgeons, the attention to detail in new technologies being offered today is allowing them to perform safer, more efficient procedures.
Cataract and vitrectomy systems
DORC announced pending upgrades to the Eva cataract and vitrectomy system. The footswitch has been redesigned and now has integrated laser control with improved ergonomics. The second improvement is in the 27-gauge light output, which improves output by 65%, and a new LED module adds another 30%, which allows optimal 27-gauge light output.
The company is also marketing a 27-gauge ultra-short vitrectomy kit that includes a trocar/cannula that is 25% shorter, a vitrectomy probe that is 25% shorter and 60% stiffer, and a light pipe that 20% shorter and 65% brighter.
Ngenuity with Datafusion has been integrated into the Constellation platform (Alcon). This innovation allows real-time display of the Constellation parameters on a monitor.
Bausch + Lomb has developed the Freeflow infusion device, which is an infusion line that is placed over the infusion cannula to maximize the internal diameter of the cannula. This improves flow rates by up to 40% and will be useful with the bi-blade vitrectomy probe to maintain infusion at high flow rates.
Internal limiting membrane stain
DORC is currently trying to bring Brilliant Blue dye to the U.S. market. The dye is currently being reviewed by the FDA.
“This is potentially the first FDA-approved staining agent for identification of the internal limiting membrane [ILM] intraoperatively,” Dr. Chow commented.
Subretinal retinal injection devices
Three new such devices are becoming available this year. Altaviz is releasing a microvolume injector with dose guidance; it is a self-powered stand-alone device, for use in stem cell and gene therapy. Besides providing visual and audible dose guidance, the injector also allows Bluetooth connectivity that displays the progress of the injection and the metrics.